ArticleBlood advances2025
Universal driving restrictions beyond 4 weeks appear unnecessary following CAR-T therapy in multiple myeloma.
Abstract read
In one paragraph
Article in Blood advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
52 authors.
Rahul BanerjeeClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.ORCID 0000-0003-3781-5441
Alicia RichardsDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
Shonali MidhaDivision of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Aimaz AfroughHematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
Faiz AnwerDivision of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.ORCID 0000-0001-6914-7439
Djordje AtanackovicDivision of Hematology/Oncology, University of Maryland, Baltimore, MD.ORCID 0000-0003-4747-488X
Shebli AtrashAtrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.
Veronika BachanovaDivision of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN.
Amer M BeitinjanehDivision of Transplantation and Cellular Therapy, University of Miami, Miami, FL.
Evguenia BhurtelDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS.
Omar Castaneda PuglianiniDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
Saurabh ChhabraDivision of Hematology/Oncology, Mayo Clinic, Phoenix, AZ.ORCID 0000-0001-9117-8696
Kara I CiceroClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
James A DavisDepartment of Pharmacy, Medical University of South Carolina, Charleston, SC.ORCID 0000-0001-7978-1652
Binod DhakalDivision of Hematology, Medical College of Wisconsin, Milwaukee, WI.ORCID 0000-0002-4377-9742
Danai DimaClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Christopher J FerreriAtrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.
Peter A ForsbergDivision of Hematology/Oncology, Colorado Blood Cancer Institute, Denver, CO.
Ciara L FreemanDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.ORCID 0000-0002-0662-6480
Megan M HerrDivision of Transplant and Cellular Therapy, Roswell Park Comprehensive Cancer Center, Buffalo, NY.ORCID 0000-0001-5768-9396
Tania JainDivision of Hematology/Oncology, Johns Hopkins University, Baltimore, MD.ORCID 0000-0001-6854-773X
Murali JanakiramDepartment of Hematology & Hematopoietic Cell Transplantation, City of Hope Cancer Center, Duarte, CA.
Jack KhouriDivision of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.ORCID 0000-0002-2473-6528
Mehmet H KocogluDivision of Hematology/Oncology, University of Maryland, Baltimore, MD.ORCID 0000-0002-9888-5737
Anupama KumarDivision of Hematology/Oncology, University of California San Francisco, San Francisco, CA.
Yuxin LiuDivision of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Frederick LockeDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
Joseph P McGuirkDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS.ORCID 0000-0002-0539-4796
Lekha MikkilineniDivision of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA.
Omar NadeemDivision of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
Ricardo D ParrondoDivision of Hematology/Oncology, Mayo Clinic, Jacksonville, FL.ORCID 0000-0002-9314-9933
Oren PasvolskyDepartment of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX.ORCID 0000-0001-9193-0059
Lauren C PeresDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
Sneha PurveyDivision of Hematology/Oncology, Virginia Commonwealth University, Richmond, VA.
Shahzad RazaDivision of Hematology and Medical Oncology, Cleveland Clinic, Lerner College of Medicine, Case Western Reserve University School of Medicine, Cleveland, OH.
Ran ReshefDivision of Hematology/Oncology, Columbia Irving Medical Center, New York City, NY.
Shambavi RichardDivision of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.
Adriana C RossiDivision of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.
Douglas W SborovDivision of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.ORCID 0000-0003-4268-2698
Leyla ShuneDivision of Hematologic Malignancies and Cellular Therapeutics, The University of Kansas Medical Center, Westwood, KS.
Charlotte B WagnerDivision of Hematology/Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT.ORCID 0000-0003-0568-0781
Saurabh S ZanwarDivision of Hematology/Oncology, Mayo Clinic, Rochester, MN.
Surbhi SidanaDivision of Transplantation and Cell Therapy, Stanford Cancer Center, Palo Alto, CA.ORCID 0000-0003-3288-7614
Krina K PatelDepartment of Lymphoma Myeloma, MD Anderson Cancer Center, Houston, TX.ORCID 0000-0002-8894-027X
Doris K HansenDepartment of Blood and Marrow Transplant and Cellular Immunotherapy, Moffitt Cancer Center, Tampa, FL.
Shaji K KumarDivision of Hematology/Oncology, Mayo Clinic, Rochester, MN.ORCID 0000-0001-5392-9284
Yi LinDivision of Hematology/Oncology, Mayo Clinic, Rochester, MN.
Thomas G MartinDivision of Hematology/Oncology, University of California San Francisco, San Francisco, CA.
Peter M VoorheesAtrium Health Levine Cancer Institute, Wake Forest University School of Medicine, Charlotte, NC.ORCID 0000-0003-1661-718X
Larry D AndersonHematologic Malignancies and Cellular Therapy Program, Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.ORCID 0000-0002-6531-9595
Andrew J CowanClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA.
Gurbakhash KaurDivision of Hematology and Medical Oncology, Mount Sinai Tisch Cancer Center, New York City, NY.ORCID 0000-0002-2510-6536
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.